Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathologic changes associated with androgen deprivation therapy for prostate cancer.

W M Murphy1, M S Soloway, G H Barrows

  • 1Department of Pathology, Baptist Memorial Hospital, Memphis, TN.

Cancer
|August 15, 1991
PubMed
Summary

Androgen deprivation therapy using leuprolide and flutamide alters prostate cancer histology, primarily affecting neoplastic gland size and distribution. This suppression, not ablation, of cancer cells requires careful histologic assessment to understand treatment effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient tolerability during office cystoscopy and bladder tumor cauterization: a multivariate analysis of risk factors.

Actas urologicas espanolas·2022
Same author

Surveillance and office management of low-grade Ta bladder tumors.

Actas urologicas espanolas·2022
Same author

Active surveillance for low-risk prostate cancer: knowledge, acceptance and practice among urologists.

Prostate cancer and prostatic diseases·2011
Same author

Chemotherapy of experimental transitional-cell carcinoma.

Urology·2011
Same author

Comparison of urologist reimbursement for managing patients with low-risk prostate cancer by active surveillance versus total prostatectomy.

Prostate cancer and prostatic diseases·2010
Same author

Presentation and outcome following radical cystectomy in Hispanics with bladder cancer.

International braz j urol : official journal of the Brazilian Society of Urology·2008

Area of Science:

  • Oncology
  • Pathology
  • Urology

Background:

  • Androgen deprivation therapy (ADT) is a cornerstone in managing advanced prostate cancer.
  • Leuprolide and flutamide are commonly used agents for ADT, inducing significant hormonal changes.
  • Understanding treatment-related histologic changes is crucial for accurate pathologic assessment.

Purpose of the Study:

  • To evaluate pathologic changes in prostate glands following ADT with leuprolide +/- flutamide.
  • To correlate histologic alterations with treatment and initial tumor characteristics.
  • To assess the impact of ADT on prostate cancer cell morphology.

Main Methods:

  • Light microscopic examination of pre- and post-treatment prostate tissue.
  • Visual discrimination and quantitative measurements of neoplastic gland size and distribution.

Related Experiment Videos

  • Histologic assessment correlated with tumor grade, clinical stage, and prostate-specific antigen expression.

    • Main Results:

    • Treatment-related alterations in neoplastic gland size and distribution observed in 60% of cases via visual inspection.
    • Quantitative measurements revealed glandular changes in a higher percentage of cases.
    • Histologic patterns were not specific to leuprolide/flutamide; absence of significant necrosis suggests suppression rather than ablation.

    Conclusions:

    • ADT with leuprolide/flutamide induces distinct but non-specific histologic changes in prostate cancer.
    • The observed effects suggest a suppressive rather than ablative mechanism of action.
    • Accurate histologic assessment is achievable with thorough examination and awareness of drug-induced morphologic variations.